Funder
NHMRC
National Breast Cancer Foundation
Australian Government Department of Industry Innovation and Science
Reference28 articles.
1. Trastuzumab-containing regimens for metastatic breast cancer;Balduzzi;Cochrane Database Syst Rev,2014
2. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001
3. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study;Swain;Lancet Oncol,2020
4. Trastuzumab for metastatic breast cancer: real world outcomes from an Australian whole-of-population cohort (2001-2016);Daniels;Breast,2018
5. Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016);Daniels;Breast Canc Res Treat,2018
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献